Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients

Patients with advanced Parkinson's disease (PD) experience body weight loss and reductions in the most common cardiovascular risk factors. At present, the pathogenetic mechanisms involved have not been elucidated. Increased serum concentrations of adiponectin, which possesses antiatherogenic an...

Full description

Saved in:
Bibliographic Details
Main Authors: Erica Cassani, Raffaella Cancello, Ferruccio Cavanna, Sabrina Maestrini, Anna Maria Di Blasio, Antonio Liuzzi, Gianni Pezzoli, Michela Barichella
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.4061/2011/624764
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items